Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03796689 · ClinicalTrials.gov registry record · NA
The PCORnet Blood Pressure Home Monitoring Study
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 2,238
- Enrollment target
NCT03796689 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 2,238 participants.
The verdict
NCT03796689, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,238 participants
- Enrollment target
Study Summary
The PCORnet Blood Pressure Home Monitoring (BP HOME) Study is a patient-level randomized controlled trial that will compare the effectiveness of home blood pressure monitoring (HPBM) with versus without a linked Smartphone application ("app") for helping patients with uncontrolled hypertension achieve a reduction in systolic blood pressure. The trial will be conducted within the National Patient-Centered Clinical Research Network (PCORnet), which supports a research network that enables distributed querying of EHR data in a common data model. It will also use the Eureka Research Platform, an online research platform hosted by UCSF that supports eConsent, online surveys, and data collection from devices such as HBPMs. Data from these two data sources will be used together to accomplish the study aims. Given that HBPM is the guideline-recommended standard of care (without specification of Smartphone linkage), the HPBM devices and the app are all commercially available and currently in use, and that clinicians, with input from patients, will maintain full control of how BP is clinically managed, we believe participation in the project poses minimal risk to participants.
Interventions
- DEVICE Smartphone-linked HBPM and associated app
- DEVICE Standard HBPM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,238 participants |
| Start Date | 2019-08-15 |
| Est. Completion | 2021-10-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03796689
The ClinicalTrials.gov registry entry for NCT03796689 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,238 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Smartphone-linked HBPM and associated app is the first listed.
NCT03796689 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03796689 about?
NCT03796689 is a clinical study titled "The PCORnet Blood Pressure Home Monitoring Study". The PCORnet Blood Pressure Home Monitoring (BP HOME) Study is a patient-level randomized controlled trial that will compare the effectiveness of home blood pressure monitoring (HPBM) with versus without a linked Smartphone application ("app") for helping patients with uncontrolled hypertension achie...
What is the current status of trial NCT03796689?
This trial is currently completed. It is a NA study. The enrollment target is 2,238 participants. The study started on 2019-08-15. Estimated completion is 2021-10-23.
What interventions are being tested in trial NCT03796689?
The interventions under investigation include: Smartphone-linked HBPM and associated app (DEVICE), Standard HBPM (DEVICE).
Who is sponsoring clinical trial NCT03796689?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.